Editorial
doi: 10.1136/bmj.330.7496.857.
Drugs for Alzheimer's disease and related dementias
- PMID: 15831849
- PMCID: PMC556143
- DOI: 10.1136/bmj.330.7496.857
Item in Clipboard
Editorial
Drugs for Alzheimer's disease and related dementias
BMJ.
.
No abstract available
Comment on
-
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.BMJ. 2005 Apr 16;330(7496):874. doi: 10.1136/bmj.38369.459988.8F. Epub 2005 Feb 18. BMJ. 2005. PMID: 15722369 Free PMC article. Clinical Trial.
Similar articles
-
Current issues in dementia pharmacotherapy.Am J Manag Care. 2007 Dec;13 Suppl 8:S198-202. Am J Manag Care. 2007. PMID: 18095783 Review.
-
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.Clin Geriatr Med. 2004 Feb;20(1):59-68. doi: 10.1016/j.cger.2003.11.002. Clin Geriatr Med. 2004. PMID: 15062487 No abstract available.
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.World J Biol Psychiatry. 2011 Feb;12(1):2-32. doi: 10.3109/15622975.2010.538083. World J Biol Psychiatry. 2011. PMID: 21288069 Review.
-
Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.Int J Geriatr Psychiatry. 2007 Apr;22(4):380-1. doi: 10.1002/gps.1667. Int J Geriatr Psychiatry. 2007. PMID: 17380475 Clinical Trial. No abstract available.
-
Neuroleptic drugs in dementia: benefits and harm.Nat Rev Neurosci. 2006 Jun;7(6):492-500. doi: 10.1038/nrn1926. Nat Rev Neurosci. 2006. PMID: 16715057 Review.
Cited by
-
Management of the behavioral and psychological symptoms of dementia.Clin Interv Aging. 2007;2(4):611-21. doi: 10.2147/cia.s1698. Clin Interv Aging. 2007. PMID: 18225462 Free PMC article. Review.
-
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.J Psychiatry Neurosci. 2006 Nov;31(6):369-76. J Psychiatry Neurosci. 2006. PMID: 17136214 Free PMC article. Review.
References
-
- Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatrics 2002;14: 389-404. - PubMed
-
- Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 2001;49: 1590-9. - PubMed
-
- Aalten P, de Vugt ME, Lousberg R, Korten E, Jaspers N, Senden B, et al. Behavior problems in dementia: as factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 2003;15: 99-105. - PubMed
-
- Cohen-Mansfield J, Libin A. Assessment of agitation in elderly patients with dementia: correlations between informant rating and direct observation. Int J Geriatr Psychiatry 2004;19: 881-91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
